S
Seung-Mo Hong
Researcher at University of Ulsan
Publications - 383
Citations - 21628
Seung-Mo Hong is an academic researcher from University of Ulsan. The author has contributed to research in topics: Pancreatic cancer & Cancer. The author has an hindex of 53, co-authored 361 publications receiving 17907 citations. Previous affiliations of Seung-Mo Hong include University of Virginia Health System & Johns Hopkins University School of Medicine.
Papers
More filters
Journal ArticleDOI
Validation of the eighth edition of the American Joint Committee on Cancer staging system for ampulla of Vater cancer
Sung Joo Kim,Soyeon An,Hyo Jeong Kang,Joo Young Kim,Min Ah Jang,Jae Hoon Lee,Ki Byung Song,Dae Wook Hwang,HyungJun Cho,Song Cheol Kim,Eunsil Yu,Seung-Mo Hong +11 more
TL;DR: The eighth edition T category for ampullary cancer does not stratify patients accurately with regard to prognosis, and modification of the current T category with eliminating subcategories is a better way for determining prognosis of ampulla of Vater cancer.
Journal ArticleDOI
MDM2 Amplification in Intrahepatic Cholangiocarcinomas: Its Relationship With Large-Duct Type Morphology and Uncommon KRAS Mutations
Sung Joo Kim,Masayuki Akita,You-Na Sung,Kohei Fujikura,Jae Hoon Lee,Shin Hwang,Eunsil Yu,Kyoko Otani,Seung-Mo Hong,Yoh Zen +9 more
TL;DR: In this paper, the authors used dual-color in situ hybridization for MDM2, immunohistochemistry for p53 and SMAD4, and gene sequencing for KRAS and IDH1/2.
Journal ArticleDOI
Feasibility of HER2-Targeted Therapy in Advanced Biliary Tract Cancer: A Prospective Pilot Study of Trastuzumab Biosimilar in Combination with Gemcitabine Plus Cisplatin
Hyehyun Jeong,Jae Ho Jeong,Kyu-Pyo Kim,Sang Soo Lee,Dongwook Oh,Do Hyun Park,Tae Jun Song,Yangsoon Park,Seung-Mo Hong,Baek-Yeol Ryoo,Changhoon Yoo +10 more
TL;DR: In this article, the preliminary efficacy/safety of first-line trastuzumab-pkrb plus GemCis in patients with advanced biliary tract cancer (BTC) was evaluated.
Journal ArticleDOI
TFAP2E Methylation Status and Prognosis of Patients with Radically Resected Colorectal Cancer
Seong Joon Park,Seung-Mi Kim,Yong Sang Hong,Jae-Lyun Lee,Jeong Eun Kim,Kyu-Pyo Kim,Seung-Mo Hong,Dong-Hoon Jin,Chan Wook Kim,Yong Sik Yoon,In Ja Park,Seok-Byung Lim,Chang Sik Yu,Jin Cheon Kim,Tae Won Kim +14 more
TL;DR: TFAP2E hypermethylation is associated with good clinical outcomes and may be considered as an independent prognostic factor in patients with curatively resected CRCs.
Journal ArticleDOI
Superficial vs deep pancreatic parenchymal invasion in the extrahepatic bile duct carcinomas: a significant prognostic factor.
TL;DR: It is recommended that a specific remark on the pathology report about the presence or absence of parenchymal invasion and the depth of invasion of the pancreas is required for managing patients and determining the prognosis.